Platelet-rich plasma therapy, also known as PRP therapy or autologous conditioned plasma (ACP) therapy, harnesses the healing properties of the blood to repair damaged tissues such as cartilage, tendons, ligaments, muscles, and bone. An increasing number of individuals are opting for PRP injections to address various orthopedic conditions, including osteoarthritis. While it's predominantly used for knee osteoarthritis, it can also be applied to other joints. During the treatment, PRP is injected directly into the affected joint with the following objectives: Reduce pain, Improve joint function , Possibly slow, halt, or even repair damage to cartilage

PRP contains a concentrated mixture of platelets, which serve as reservoirs for growth factors and proteins crucial for tissue regeneration and healing. When injected into the affected joint, PRP aims to alleviate pain, enhance joint function, and potentially facilitate the repair of damaged cartilage, tendons, ligaments, and muscles.

Despite its widespread use, PRP therapy exhibits variability in its application. Factors such as patient characteristics, blood processing techniques, and the addition of adjunctive substances can influence the composition and efficacy of PRP injections. Understanding these variations is essential for optimizing treatment outcomes.

While PRP therapy shows considerable promise, further research is imperative to elucidate its mechanisms of action and refine its clinical application. Large-scale clinical studies are needed to establish standardized protocols, assess long-term effectiveness, and identify optimal patient selection criteria for achieving optimal outcomes in arthritis and other orthopedic conditions.